U.S. Metals and Mining Stock News

NasdaqCM:SLS
NasdaqCM:SLSBiotechs

SELLAS Life Sciences (SLS) Is Up 21.8% After REGAL Trial Clears Key Continuation Review - What's Changed

In recent months, SELLAS Life Sciences Group reported encouraging activity for SLS009 in combination with AZA/VEN in relapsed/refractory AML and confirmed that the Independent Data Monitoring Committee recommended the Phase 3 REGAL trial continue without modification, with final analysis expected before year-end. This combination of positive efficacy signals and trial continuity strengthens the clinical credibility of SELLAS’s pipeline in a difficult-to-treat leukemia setting. We’ll now...
NYSE:GPN
NYSE:GPNDiversified Financial

Global Payments AI Push And Software Shift Under Spotlight At Wolfe Forum

Global Payments Inc. (NYSE:GPN) CEO Cameron Bready is scheduled to present at the Wolfe FinTech Forum. The appearance comes as the company highlights artificial intelligence initiatives across its payments and software offerings. Management has been discussing a possible shift toward a more software led business model within the payments sector. For you as an investor, this places Global Payments, a major player in merchant acquiring and payment technology, in the middle of a broader...
NYSE:RBRK
NYSE:RBRKSoftware

Is Rubrik (RBRK) Offering Value After Recent Share Price Pullback?

If you are wondering whether Rubrik at around US$54.87 is a bargain or just fairly priced, you are not alone. Many investors are asking the same question before committing fresh capital. Over the short term, the stock has moved around, with a 5.2% return over 7 days, 0.8% over 30 days, a 27.3% decline year to date and a 12.7% decline over 1 year. These figures may change how you think about both upside potential and risk. Recent coverage of Rubrik has focused on its position in the software...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

ACM Research (ACMR) Is Down 9.2% After Margin Squeeze Despite Higher 2025 Revenue - What's Changed

In late February 2026, ACM Research reported fourth-quarter 2025 revenue of US$244.43 million and full-year revenue of US$901.31 million, alongside lower quarterly and annual net income compared with the prior year as earnings per share declined. A few days later, the company filed a US$135.27 million shelf registration for 2,624,473 Class A shares tied to an ESOP-related offering, highlighting how employee ownership and equity-based compensation sit alongside rising R&D and expansion costs...
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy Profit Beat Highlights Rising Digital Margins And Dividend Support

Best Buy (NYSE:BBY) reports profit that exceeds internal expectations, supported by higher margin digital businesses including advertising and its third party marketplace. The company highlights growth from Marketplace and Ads, with partner numbers nearly doubling, and announces a 1% dividend increase. Best Buy also outlines plans for new small format stores aimed at underserved markets, paired with investment in AI powered customer experiences. For investors watching large electronics...
NYSE:AXP
NYSE:AXPConsumer Finance

Assessing American Express (AXP) Valuation After A 16% Dividend Increase

American Express (AXP) has just approved a 16% uplift in its quarterly dividend, taking the payout to $0.95 per share. For investors, this move puts fresh attention on the stock's income profile. See our latest analysis for American Express. Despite the dividend uplift and a stream of recent announcements around new stadium partnerships, AI investments and a future New York headquarters, the share price has recently come under pressure, with a 30 day share price return of 11.8% and a year to...
NYSE:BORR
NYSE:BORREnergy Services

Borr Drilling Fleet Deal Expands Backlog But Raises Leverage Questions

Borr Drilling has acquired five premium jack up rigs from Noble Corporation. The company has secured 24 new contract commitments tied to its enlarged fleet. The moves expand NYSE:BORR's operational capacity and increase its contracted work pipeline. For investors watching NYSE:BORR, this fleet deal and new contract haul comes alongside a share price of $5.86 and a 46.9% return year to date. The stock is up 152.6% over the past year and 144.9% over five years, while the three year return...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

DENTSPLY SIRONA (XRAY) Is Up 5.0% After Impairment Charges And New Guidance Reset Expectations – What’s Changed

DENTSPLY SIRONA recently reported fourth-quarter 2025 results showing sales of US$961 million and a net loss of US$146 million, recorded sizeable non-cash impairment charges tied to weaker demand in key technology and implant segments, issued 2026 net sales guidance of US$3.5–3.6 billion, and announced board additions plus an expanded technology distribution partnership with Burkhart Dental Supply. These updates together reveal a company working to realign underperforming businesses, broaden...
NYSE:GNRC
NYSE:GNRCElectrical

A Look At Generac Holdings (GNRC) Valuation After Its 2026 Outlook And Data Center Growth Story

Generac Holdings (GNRC) is back in focus after issuing a 2026 outlook that emphasizes large-scale data center generators and growing home automation, along with renewed attention on home standby units following severe winter outages. See our latest analysis for Generac Holdings. That 2026 outlook has arrived after a sharp rebound in sentiment, with a 30-day share price return of 29.21% and a 56.55% year to date share price return. The 1-year total shareholder return of 69.82% contrasts with a...
NYSE:NU
NYSE:NUBanks

Assessing Nu Holdings (NU) Valuation After Strong Annual Earnings And Latin America Expansion

Nu Holdings (NU) is back in focus after reporting full year 2025 results that showed higher net interest income, net income and earnings per share. This has drawn fresh attention to the stock’s recent pullback. See our latest analysis for Nu Holdings. Despite robust full year 2025 results and upcoming investor visibility at a major technology and telecom conference, Nu Holdings’ recent share price return has softened, with a 7 day share price return of 9.91% and a 30 day share price return of...
NYSE:RDW
NYSE:RDWAerospace & Defense

Redwire Weighs ELSA Opportunity And Edge Autonomy Integration Against Risks

Redwire (NYSE:RDW) has introduced its Extensible Low-Profile Solar Array, or ELSA, a new high-performance, low-mass solar array designed for rapid, scalable production for mass-manufactured satellites. The company is also integrating its recent Edge Autonomy acquisition, expanding its presence in autonomous surveillance and reconnaissance technologies used in commercial and defense applications. These moves come as demand grows for power efficient satellite platforms and intelligence systems...
NasdaqGS:UBSI
NasdaqGS:UBSIBanks

Evaluating United Bankshares (UBSI) Valuation After Recent Share Price Moves

Context for United Bankshares after recent moves United Bankshares (UBSI) has drawn fresh attention after recent share price moves, with the stock closing at $41.38. Investors are weighing this level against the bank's fundamentals and recent return profile. See our latest analysis for United Bankshares. While the latest share price of $41.38 comes after a softer 7 day and 30 day share price return, the 90 day share price return of 8.64% and 1 year total shareholder return of 21.98% suggest...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Axon Q4 AI Growth Strengthens Public Safety Story As Insiders Sell

Axon Enterprise (NasdaqGS:AXON) reported strong Q4 results, with management highlighting what it described as industry leading growth in AI powered public safety tools. The company saw rapid uptake of its generative AI report writing tool, Draft One, among law enforcement customers. Axon expanded further into emergency communications through acquisitions that broaden its public safety technology suite. Recent insider selling by senior executives, including the COO and CFO, has drawn...
NYSE:VIK
NYSE:VIKHospitality

A Look At Viking Holdings (VIK) Valuation After Strong Bookings And Recent Share Price Pullback

Key business snapshot for Viking Holdings Viking Holdings (VIK) has been drawing attention after recent trading, with shares last closing at $75.28. For investors, the immediate reference points are its recent returns and the scale of its current operations. See our latest analysis for Viking Holdings. Recent trading has been choppy, with a 1 day share price return of a 1.49% decline and a 7 day share price return of a 4.93% decline. However, a 90 day share price return of 11.34% and a 1 year...
NYSE:PWR
NYSE:PWRConstruction

What Quanta Services (PWR)'s Upbeat 2026 Outlook After Strong 2025 Results Means For Shareholders

Quanta Services recently reported fourth‑quarter 2025 results and full‑year figures, with sales of US$7,841.95 million for the quarter and US$28.48 billion for the year, alongside net income of US$315.45 million for the quarter and US$1.03 billion for the year. The company also issued 2026 guidance calling for revenues of about US$33.25–US$33.75 billion and adjusted diluted EPS of US$12.65–US$13.35, underpinned by recent acquisitions and strength in its Electric division. We’ll now examine...
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

Will Jefferies’ Backlog-Fueled Upgrade Reshape Fluence Energy's (FLNC) Investment Narrative?

In recent days, Jefferies upgraded Fluence Energy from Hold to Buy, pointing to improved U.S. market conditions and a restated fiscal 2026 revenue and adjusted EBITDA outlook. Fluence’s record project backlog of over US$5.50 billion, supported by almost US$750 million in new quarterly orders, underscores mounting demand from data centers, utilities, and industrial customers. We’ll now examine how Jefferies’ upgrade, centered on Fluence’s record backlog strength, may influence the company’s...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Assessing Urban Outfitters (URBN) Valuation After Mixed Earnings And Ongoing Share Price Pressure

Urban Outfitters (URBN) is back in focus after reporting fourth quarter and full year results, with higher sales in both periods, a mixed picture on net income, and a completed multi year share repurchase program. See our latest analysis for Urban Outfitters. The latest earnings release and completed buyback come after a weaker 30-day share price return of a 7.85% decline and a 90-day share price return of an 11.65% decline. However, the 1-year total shareholder return of 16.67% and 3-year...
NYSE:SGHC
NYSE:SGHCHospitality

Assessing Super Group (SGHC) Valuation After Earnings Beat, Upgraded Guidance And Higher Dividend Program

Super Group (SGHC) stock is drawing fresh attention after the company reported strong adjusted EBITDA growth and margin expansion in its latest earnings report, along with higher 2026 revenue guidance and a richer dividend program. See our latest analysis for Super Group (SGHC). The latest earnings, higher 2026 revenue guidance and the richer dividend program appear to be supporting renewed momentum, with the 30 day share price return of 23.35% and a 1 year total shareholder return of 66.64%...
NasdaqGS:DAWN
NasdaqGS:DAWNBiotechs

Why Day One Biopharmaceuticals (DAWN) Is Up 17.7% After Positive EU Opinion For OJEMDA Approval

In late February 2026, Day One Biopharmaceuticals reported fourth-quarter 2025 revenue of US$53.7 million with a US$21.3 million net loss, and the European regulator’s committee issued a positive opinion supporting conditional marketing authorization of OJEMDA for relapsed or refractory BRAF‑altered pediatric low‑grade glioma. This combination of improving quarterly losses and progress toward conditional European approval for OJEMDA highlights both growing commercial traction and expanding...
NYSE:COF
NYSE:COFConsumer Finance

What Capital One Financial (COF)'s Earnings Miss, Fraud Probe, and Deal Integrations Mean For Shareholders

In recent weeks, Capital One reported very large year-on-year revenue growth that beat analyst expectations, but missed earnings and net interest margin estimates, while facing a new securities-fraud investigation and ongoing integration of Discover and the planned Brex acquisition. These mixed results, combined with regulatory concerns such as potential interest rate caps and insider share sales under a trading plan, highlight how execution, legal risk, and policy shifts could influence...
NYSE:HCA
NYSE:HCAHealthcare

HCA Balances ACA Earnings Hit With AI And Network Expansion Plans

HCA Healthcare, NYSE:HCA, is preparing for a financial impact linked to expected declines in Affordable Care Act insurance enrollments. The company is adjusting operations to this shift while pursuing AI integration, new emergency care centers, and leadership changes. These moves come as investors weigh the earnings impact projected for 2026 against the company’s longer term strategic initiatives. HCA Healthcare enters this period of change with its shares at $544.41, after a 71.6% return...
NasdaqGS:TCBI
NasdaqGS:TCBIBanks

How Investors May Respond To Texas Capital Bancshares (TCBI) New Debt, Insider Buying and Dividend Reaffirmation

In February 2026, Texas Capital Bancshares completed a US$400,000,000 fixed-to-floating rate senior unsecured note offering due 2032, while director Robert W. Stallings bought 40,000 Series B preferred depositary shares and the bank reaffirmed a cash dividend on those shares. Institutional investors such as JPMorgan Chase and Quantbot Technologies expanded their positions as Texas Capital also earned a Best Bank recommendation for middle market clients. We’ll now examine how this combination...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics Azer Cel Milestone Adds Depth To Autoimmune Valuation Story

TG Therapeutics and Precision BioSciences reported a new clinical milestone for azercabtagene zapreleucel in progressive multiple sclerosis. The milestone is tied to an exclusive worldwide license for autoimmune diseases between the two companies. The progress with azer cel adds a new autoimmune program alongside TG Therapeutics' existing BRIUMVI franchise. TG Therapeutics, trading on NasdaqCM:TGTX, is drawing fresh attention as it builds out its autoimmune pipeline beyond BRIUMVI. The...
NYSE:CI
NYSE:CIHealthcare

Cigna CEO Succession Tests Continuity Of Growth And Governance Story

Cigna Group (NYSE:CI) announced a CEO succession, with longtime chief executive David M. Cordani set to retire. Brian Evanko, currently a senior leader within the company, will assume the CEO role. The transition marks a significant leadership change at the top of the health services provider. Cigna Group operates as a global health services company, with a focus on medical benefits, pharmacy benefits, and related services for employers, governments, and individuals. Leadership shifts at a...